
GC16308
AZD-9291
Also known as N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide
AZD-9291 (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively· AZD-9291 overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
ChemicalCAS1421373-65-0MW499.61FormulaC28H33N7O2
- CAS number
- 1421373-65-0
- Molecular weight
- 499.61
- Formula
- C28H33N7O2
- Solubility
- ≥ 24·98mg/mL in DMSO
- InChIKey
- DUYJMQONPNNFPI-UHFFFAOYSA-N
- Catalogue number
- GC16308
- Brand
- GLPBIO
Computed properties PubChem CID 71496458 · XLogP 3.7 · TPSA 87.6 Ų · H-bond donors 2
- XLogP
- 3.7
- TPSA
- 87.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 10
- Heavy atoms
- 37
SMILES CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
Computed descriptors from PubChem (CID 71496458), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il